Arno Therapeutics to Collaborate With Clarient, Inc. for Development of Diagnostic Test
5/10/2013 9:33:45 AM
More...
|
Clarient, Inc. and ACORN Research LLC Announce a Collaboration to Standardize Testing of Most Common Cancers
12/9/2011 6:38:30 AM
More...
|
Clarient, Inc. Joins the HistoRx, Inc. Clinical Trials Network: First Commercial Lab to Provide Aqua(R) Technology for Clinical Trials
10/24/2011 2:18:16 PM
More...
|
Biocept, Inc. and Clarient, Inc. Announce Collaboration on First Test for Circulating Tumor Cells and HER2 Status in Breast Cancer Patients
8/25/2011 11:07:39 AM
More...
|
CombiMatrix Corporation (CBMX) Partners With Clarient, Inc. to Commercialize CombiMatrix Genomic Profile Tests for Cancer
4/11/2011 9:54:27 AM
More...
|
Safeguard Scientifics (SFE) Realizes $144 Million in Net Proceeds from Completion of Tender Offer for Clarient, Inc. by GE Healthcare
12/17/2010 7:39:52 AM
More...
|
Clarient, Inc. Launches Insight(R) Dx Mammostrat(R) Breast Cancer Recurrence Test
12/9/2010 7:17:13 AM
More...
|
GE Healthcare Extends Tender Offer for Clarient, Inc.
12/6/2010 8:56:49 AM
More...
|
Clarient, Inc. Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation
12/6/2010 7:58:18 AM
More...
|
Clarient, Inc.'s Board of Directors Recommends Stockholders Accept General Electric Company (GE)'s Cash Tender Offer
11/8/2010 6:55:27 AM
More...
|
|